In humans, 5% of diagnosed type-2 diabetes patients present with genetic defects in PDX1 and mutations in PDX1 define a subset of maturity-onset diabetes of the young 4 (MODY 4) (27, 28). This evidence concerns the gene PDX1 and maturity-onset diabetes of the young.